US Patients Get Cancer Drugs Faster & Pay More
11:36 EDT 10 Jul 2012 | Pharmalot
File this under the ‘big trade off.’ Between 2000 and 2011, new oncology drug approvals in the US outpaced European approvals by 33 percent. But at the same time, prices for cancer medications in Europe, on average, were 9 percent lower t..
Original Article: US Patients Get Cancer Drugs Faster & Pay More
More From BioPortfolio on "US Patients Get Cancer Drugs Faster & Pay More"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
